Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0195 | 0.463 | 0.463 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0195 | 0.463 | 1 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0195 | 0.463 | 0.463 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0195 | 0.463 | 0.7204 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.004 | 0 | 0.5 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0195 | 0.463 | 0.6893 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.004 | 0 | 0.5 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0195 | 0.463 | 1 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.004 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0255 | 0.6427 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0446 | 0.0663 |
Mycobacterium leprae | Probable lipase LipE | 0.004 | 0 | 0.5 |
Onchocerca volvulus | 0.0055 | 0.0446 | 1 | |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0195 | 0.463 | 1 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0195 | 0.463 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.004 | 0 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0265 | 0.6717 | 1 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0055 | 0.0446 | 0.0962 |
Mycobacterium ulcerans | hypothetical protein | 0.004 | 0 | 0.5 |
Brugia malayi | isocitrate dehydrogenase | 0.0195 | 0.463 | 0.6893 |
Trichomonas vaginalis | esterase, putative | 0.004 | 0 | 0.5 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0195 | 0.463 | 0.463 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.004 | 0 | 0.5 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.004 | 0 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0265 | 0.6717 | 1 |
Brugia malayi | Isocitrate dehydrogenase | 0.0195 | 0.463 | 0.6893 |
Brugia malayi | MH2 domain containing protein | 0.0265 | 0.6717 | 1 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0195 | 0.463 | 1 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0195 | 0.463 | 0.5 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0195 | 0.463 | 1 |
Echinococcus multilocularis | tumor protein p63 | 0.0375 | 1 | 1 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0195 | 0.463 | 0.463 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.004 | 0 | 0.5 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0195 | 0.463 | 1 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0195 | 0.463 | 1 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0195 | 0.463 | 1 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0195 | 0.463 | 0.463 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.004 | 0 | 0.5 |
Mycobacterium ulcerans | lipase LipD | 0.004 | 0 | 0.5 |
Mycobacterium ulcerans | beta-lactamase | 0.004 | 0 | 0.5 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0195 | 0.463 | 0.463 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CD50 (functional) | = 0.4 mg kg-1 | Trypanocidal Activity at I.C.E. value 0.44 when administered subcutaneously. | ChEMBL. | 2296025 |
CD50 (functional) | = 0.4 mg kg-1 | Trypanocidal Activity at I.C.E. value 0.44 when administered subcutaneously. | ChEMBL. | 2296025 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.